Profusa Common Stock Net Income
| PFSA Stock | 4.43 0.32 7.79% |
As of the 10th of February, Profusa Common holds the Coefficient Of Variation of (1,502), risk adjusted performance of (0.04), and Variance of 192.23. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Profusa Common, as well as the relationship between them.
Profusa Common's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Profusa Common's valuation are provided below:We have found ninety-six available trending fundamental ratios for Profusa Common Stock, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Profusa Common Stock recent market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. As of February 10, 2026, Enterprise Value is expected to decline to about 94.1 M This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -10.6 M | -11.1 M | |
| Net Loss | -10.6 M | -11.1 M | |
| Net Loss | (0.25) | (0.27) |
Profusa | Net Income | Build AI portfolio with Profusa Stock |
Analyzing Profusa Common's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Profusa Common's current valuation and future prospects.
Latest Profusa Common's Net Income Growth Pattern
Below is the plot of the Net Income of Profusa Common Stock over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Profusa Common Stock financial statement analysis. It represents the amount of money remaining after all of Profusa Common Stock operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Profusa Common's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Profusa Common's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (9.23 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Profusa Net Income Regression Statistics
| Arithmetic Mean | (10,894,572) | |
| Coefficient Of Variation | (22.28) | |
| Mean Deviation | 1,126,245 | |
| Median | (10,310,000) | |
| Standard Deviation | 2,427,665 | |
| Sample Variance | 5.9T | |
| Range | 11M | |
| R-Value | (0.21) | |
| Mean Square Error | 6T | |
| R-Squared | 0.05 | |
| Significance | 0.41 | |
| Slope | (102,491) | |
| Total Sum of Squares | 94.3T |
Profusa Net Income History
Other Fundumenentals of Profusa Common Stock
Profusa Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Profusa Common is extremely important. It helps to project a fair market value of Profusa Stock properly, considering its historical fundamentals such as Net Income. Since Profusa Common's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Profusa Common's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Profusa Common's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profusa Common. Anticipated expansion of Profusa directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Profusa Common assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Profusa Common Stock using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Profusa Common's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Profusa Common's market price to deviate significantly from intrinsic value.
It's important to distinguish between Profusa Common's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profusa Common should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Profusa Common's market price signifies the transaction level at which participants voluntarily complete trades.
Profusa Common 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Profusa Common's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Profusa Common.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Profusa Common on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Profusa Common Stock or generate 0.0% return on investment in Profusa Common over 90 days. Profusa Common is related to or competes with Acurx Pharmaceuticals, Innovative Eyewear, Sunshine Biopharma, HCW Biologics, Biofrontera, Adial Pharmaceuticals, and Aprea Therapeutics. Profusa Common is entity of United States More
Profusa Common Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Profusa Common's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Profusa Common Stock upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 114.89 | |||
| Value At Risk | (19.64) | |||
| Potential Upside | 12.05 |
Profusa Common Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Profusa Common's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Profusa Common's standard deviation. In reality, there are many statistical measures that can use Profusa Common historical prices to predict the future Profusa Common's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (2.46) | |||
| Treynor Ratio | 0.2651 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Profusa Common's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Profusa Common February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | 0.2751 | |||
| Mean Deviation | 8.39 | |||
| Coefficient Of Variation | (1,502) | |||
| Standard Deviation | 13.86 | |||
| Variance | 192.23 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (2.46) | |||
| Treynor Ratio | 0.2651 | |||
| Maximum Drawdown | 114.89 | |||
| Value At Risk | (19.64) | |||
| Potential Upside | 12.05 | |||
| Skewness | 2.63 | |||
| Kurtosis | 16.36 |
Profusa Common Stock Backtested Returns
Profusa Common Stock maintains Sharpe Ratio (i.e., Efficiency) of -0.0795, which implies the firm had a -0.0795 % return per unit of risk over the last 3 months. Profusa Common Stock exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Profusa Common's Variance of 192.23, coefficient of variation of (1,502), and Risk Adjusted Performance of (0.04) to confirm the risk estimate we provide. The company holds a Beta of -3.52, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Profusa Common are expected to decrease by larger amounts. On the other hand, during market turmoil, Profusa Common is expected to outperform it. At this point, Profusa Common Stock has a negative expected return of -1.14%. Please make sure to check Profusa Common's skewness, as well as the relationship between the rate of daily change and price action indicator , to decide if Profusa Common Stock performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.63 |
Good predictability
Profusa Common Stock has good predictability. Overlapping area represents the amount of predictability between Profusa Common time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Profusa Common Stock price movement. The serial correlation of 0.63 indicates that roughly 63.0% of current Profusa Common price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.63 | |
| Spearman Rank Test | 0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 1.45 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Profusa Net Interest Income
Net Interest Income |
|
Based on the recorded statements, Profusa Common Stock reported net income of (9.23 Million). This is 102.7% lower than that of the Health Care Technology sector and 103.88% lower than that of the Health Care industry. The net income for all United States stocks is 101.62% higher than that of the company.
Profusa Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Profusa Common's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Profusa Common could also be used in its relative valuation, which is a method of valuing Profusa Common by comparing valuation metrics of similar companies.Profusa Common is currently under evaluation in net income category among its peers.
Profusa Fundamentals
| Operating Margin | (61.49) % | ||||
| Current Valuation | 17.88 M | ||||
| Shares Outstanding | 41.76 M | ||||
| Shares Owned By Insiders | 26.36 % | ||||
| Shares Owned By Institutions | 1.60 % | ||||
| Number Of Shares Shorted | 3.01 M | ||||
| Price To Sales | 104.68 X | ||||
| Gross Profit | 75 K | ||||
| EBITDA | (4.81 M) | ||||
| Net Income | (9.23 M) | ||||
| Total Debt | 48.21 M | ||||
| Book Value Per Share | (22.16) X | ||||
| Cash Flow From Operations | (2.07 M) | ||||
| Short Ratio | 0.57 X | ||||
| Earnings Per Share | (0.53) X | ||||
| Beta | -0.22 | ||||
| Market Capitalization | 7.85 M | ||||
| Total Asset | 3.07 M | ||||
| Retained Earnings | (124.96 M) | ||||
| Working Capital | (56.87 M) | ||||
| Net Asset | 3.07 M |
About Profusa Common Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Profusa Common Stock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Profusa Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Profusa Common Stock based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Profusa Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Profusa Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Profusa Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Profusa Common Stock Stock:Check out You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profusa Common. Anticipated expansion of Profusa directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Profusa Common assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Profusa Common Stock using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Profusa Common's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Profusa Common's market price to deviate significantly from intrinsic value.
It's important to distinguish between Profusa Common's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profusa Common should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Profusa Common's market price signifies the transaction level at which participants voluntarily complete trades.